𝓦𝓱𝔂 𝓭𝓸𝓮𝓼 𝓲𝓽 𝓮𝔁𝓲𝓼𝓽?

This article is intended to inspire better patient care, not to criticize it. At The Way To My Heart, we believe that every patient deserves a better quality of life. So, we are committed to fighting for life and limb, putting an end to needless amputations!

Dr. Athar Ansari | California Heart & Vascular Clinic | PATIENT NOMINATION VIDEO

Dr. Jihad Mustapha |Advanced Cardiac & Vascular | PATIENT NOMINATION VIDEO

2020 PAD Awareness Month "Patient Champion": Dr. Ashish Gupta | AWARD VIDEO

2020 GLOBAL Vascular Doctor of the Year: Dr. Lorenzo Patrone: READ ARTICLE

It is an exciting time of healthcare innovation with investors doubling down this year. According to, total healthcare funding is up nearly 19% from the same period a year ago to $9.1 billion. Will all of this investment in innovation translate into better patient outcomes? Vascular Cures Chairman Ed Yu is committed to turning innovation into a conversation that puts patients before profits to create a sustainable long-term impact on global health. Watch this interview to better understand the critical stakeholders who must be at the table to create a sustainable impact in the prevention, diagnosis, treatment, and long-term management of vascular diseases.

Dermaflow's CEO explains how how they've applied electronic measuring systems used in other heavy industries such as oil, in the medical industry. DermaFlow's initial market is to measure peripheral blood flow. To be able to monitor the peripheral blood flow and correlate its changes to a specific disease state or health condition provides a HUGE advantage for early detection of deterioration over a broad medical platform. Dermaflow's suite of products are designed to help doctors in-office and patients remotely to spot insufficient blood flow in the lower limbs in even seemingly healthy patients.

Alucent has designed a more natural option to keep the vessel open. It's one that’s activated by a deep blue light that creates a scaffolding inside the vessel to keep it open. In this interview, CEO Dr. Myles Greenberg explains how they're going to use an additional raise of $35 million dollars to support clinical trials, one of which has recently begun.

In this discussion, A Canadian friend with PAD impresses upon physicians the importance of listening to patients and not delaying treatment for lifestyle-limiting claudication and rest pain. Watch to the end as this inspiring woman, who thought she was only at the table to raise awareness of the experiences of CLTI Patients, gets the tables turned on her when a member of the physician panel provides a real-time revelation that could change her future.

READ FULL STORY